InvestorsHub Logo
Followers 4
Posts 1273
Boards Moderated 0
Alias Born 09/06/2017

Re: None

Thursday, 10/06/2022 7:35:37 PM

Thursday, October 06, 2022 7:35:37 PM

Post# of 27416
8-K just filed, "retire from her role as CFO" Kathleen Bloch.

On September 30, 2022, Ms. Kathleen P. Bloch notified CytoSorbents Corporation (the “Company”) and the Board of Directors (the “Board”) of her decision to retire from her role as Chief Financial Officer of the Company, effective as of March 31, 2023. Ms. Bloch and the Company currently expect to enter into a consulting arrangement under which Ms. Bloch will continue to provide services to the Company in a limited capacity following the effective date of her retirement. Ms. Bloch has also agreed to assist the Company during its transition to a replacement Chief Financial Officer. On October 7, 2022, prior to market open, the Company intends to formally issue a press release announcing Ms. Bloch's retirement, a copy of which is included as Exhibit 99.1 hereto.

https://ih.advfn.com/stock-market/NASDAQ/cytosorbents-CTSO/stock-news/89242335/current-report-filing-8-k
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News